Muralidharan Anbalagan

Assistant Professor

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Muralidharan Anbalagan is an Assistant Professor at Tula University in the United States. His research areas include breast cancer metastasis prevention, the effects of various compounds on breast cancer cells, and the role of specific proteins in cancer progression. Dr. Anbalagan's recent publications focus on innovative treatment strategies for breast and colon cancers, as well as the genetic mutations relevant to prostate cancer. He is dedicated to advancing the understanding of cancer biology and developing targeted therapies.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (1)

Yohei Takeshita

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Muralidharan Anbalagan

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

The greater palatine nerve and artery both supply the maxillary teeth

Bone Targeted Parathyroid Hormone Antagonists for Prevention of Breast Cancer Bone Metastases

Heparin, Heparin-like Molecules, and Heparin Mimetics in Breast Cancer: A Concise Review

Dataset of transcriptomic changes induced by naringenin treatment in MCF-7 breast cancer cells

Targeting colon cancer stem cells using novel doublecortin like kinase 1 antibody functionalized folic acid conjugated hesperetin encapsulated chitosan nanoparticles

Novel bone-targeted parathyroid hormone-related peptide antagonists inhibit breast cancer bone metastases

Acute toxicity evaluation of a novel ceramide analog for the treatment of breast cancer

Tamoxifen induces stem-like phenotypes and multidrug resistance by altering epigenetic regulators in ERα+ breast cancer cells

ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer

Somatic mutations in the DNA repairome in prostate cancers in African Americans and Caucasians

Collaborators (1)

Yohei Takeshita

Make your next move.